Mats Grahn, Chief Executive Officer
Mats brings more than 25 years experiences in senior leading positions within the life science and diagnostics industry. He contributes with an extensive experience in business and strategic development, marketing, product management, product development and market access. Mats has a track record of leading international commercial operational organizations, restructuring of marketing organizations, integration of acquired companies as well as managing new start-ups. Much of his experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. Previous positions include CVP Marketing Dako A/S, VP Product Management GE Healthcare, VP Marketing Amersham Biosciences, VP Laboratory Separations Pharmacia Biotech and VP Prevas Bioinformatics. Mats Grahn holds a MSc in Engineering Physics from Lund University, Sweden.
Rolf Ehrnström, Chief Scientific Officer
Rolf has more than 30 years of scientific, technical and commercial experience from small, medium and large sized life science and diagnostics companies on the international arena. The last 20 years he served in senior executive management roles.
Rolf contributes with an extensive experience in product-, technology- and strategic development in the life science and diagnostics industry. He has a track record of leading large operational organizations (>200 staff), restructuring of large R&D organizations, integration of acquired companies as well as managing rapid growth in new start-ups. Much of his experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. His responsibilities has ranged from all technical disciplines within R&D as well as IP, Regulatory, Medical & Clinical Affairs, Scientific Relations/Profiling and External Scientific Collaborations. In recent years a special focus have been in the fields of Personlized Medicine, companion diagnostics and technology innovation where Dako has played a leading role within its field.
Important previous positions include: CSO Dako-Agilent, CVP R&D Dako A/S, VP R&D Gyros AB, Science Director Amersham Biosciences, Senior Scientific Advisor Amersham Pharmacia Biotech, Senior Program Manager MicroArrays Amersham-Pharmacia Biotech, Director R&D Molecular Biology Pharmacia Biotech. In the CV are also roles as board member in Scientific organization committees and small start-ups. Rolf Ehrnström holds a MSc in biochemistry & biotechnology engineering from Royal Institute of Technology, Stockholm, Sweden.
Christer Wingren, Chief Technology Officer
Professor Wingren is in addition to his role as CTO at Immunovia a lecturer at the Dept. of Immunotechnology within CREATE Health Translational Cancer Center at Lund University, Sweden. Professor Wingren directs a research group working on the development of recombinant antibody microarrays for high-throughput disease proteomics (“unlocking biomarker discovery”), the Immunovia platform, with a particular focus on oncoproteomics and autoimmunity. The research is conducted in a translational manner, going from the bed-to-bench and back again, with the goal to define serum, plasma, and urine biomarkers for disease diagnosis, prognosis, and classification. In 2014, he was promoted to Professor in Immunotechnology. Prior to joining Immunotechnology in 1999, Dr. Wingren pursued his post-doctoral training in structural biology in the laboratory of Prof. Ian Wilson at the Scripps Research Institute, La Jolla, USA (1997-1999). Dr. Wingren received his Ph.D. in biochemistry at Lund University in 1997, and a B.Sc. in chemistry in 1991.
Hans Liljenborg, Chief Financial Officer
Hans Liljenborg has a degree as subject teacher in Business Administration and Mathematics from Lund University, Sweden. Hans has long experience as Financial Manager for growing, global medical technology companies and is currently Finance Director at Physio Control Inc and Jolife AB. Hans is Finance Manager at Vivoline Medical AB, listed on Nasdaq First North in March 2015. He also operates an own accounting firm.
Current assignments: Hans Liljenborg is a board member of ADAYS AB and deputy board member in Entreprenörskompetens i Lund AB, IES Interactive Executive Search AB, Gantus Training AB. Hans is also holder of Prosperus and auditor in Solbacka Trading and Bostadsrättsföreningen Långgårdsgatan 17.
Laura Chirica, Chief Commercial Officer
With more than 14 years experiences in leading commercial positions within the life science and diagnostics industry, Laura contributes with an extensive experience in business, organization and strategic development, sales, strategic and tactical marketing, product management and product support. She has a track record of leading and restructuring international sales and marketing organizations, driving business development, champion integration of acquired companies as well as developing branding and market communication platforms. Much of her experience comes from leadership in multinational management teams and organizations in Scandinavia, Europe, USA and Asia. Previous positions include VP Sales and Marketing Euro Diagnostica AB, Director Purification Technologies Europe Sartorius Stedim, Global Marketing Director Dako A/S, and Global Marketing Program Manager GE Healthcare. Laura Chirica holds a Ph.D in Biochemistry from Umeå University, Sweden, a MSc in Biochemistry and a BSc in Biotechnology.
Henrik Winther, SVP Business Development
Henrik has been at the forefront of companion diagnostics for over 10 years. He brings solid experiences within R&D, business development, regulatory, manufacturing and commercialization of IVD products. From 2006, Henrik was R&D Director at Dako A/S and spearheaded the design responsibility of their most successful product, the HercepTest CDx assay, and later was Head of Dako Business Development and involved in the acquisition of Dako by Agilent Technologies. From 2013-2017, he continued at Agilent in Santa Barbara, CA, as Vice President and General Manager – as well as head of the R&D function – of the Companion Diagnostics Division, and in addition to scaling up the division, increased revenues significantly through fee-for-service collaborations with pharma and CDx-product releases. Henrik holds a DVM and PhD in cell biology and histology from University of Copenhagen. He has earlier worked as an Associate Professor within cell biology, but during the last 17 years focused on cancer diagnostics.
Linda Mellby, Laboratory Director
Linda has more than 10 years experiences of recombinant antibody microarray technology, the Immunovia platform, she has deep knowledge about platform features, technology development as well as clinical applications within oncoproteomics and autoimmunity. She has been one of the key researchers managing the development of the Immunovia antibody microarray platform for disease proteomics, conducting extensive work related to process optimizations, standardizations as well as clinical studies. Linda Mellby received her Ph.D. in Immunotechnology from Dept. of Immunotechnology within CREATE Health Translational Cancer Center, Lund University, in 2010, and a MSc in Chemistry Engineering in 2004.
Lotta Blomgren, Operations Director
Lotta has more than 30 years’ experience within the life science and diagnostics industry, whereof 15 years in leading positions. She contributes with extensive experience from leading manufacturing, quality control and logistics teams, as well as managing transfer of new products from development to commercial scale. Her track record includes strategic reorganizations of international manufacturing networks, managing people and project portfolios, as well as due diligence of potential acquirement of new companies and Contract Manufacturing (CMO).
Previous positions include VP Technical Operations at Euro Diagnostica AB, Head of Supply Chain Bioglan AB, Director Product & Technology Support Ferring A/S, Head of Process Development Ferring AB, cross functional roles within Process Development and Project Management at Astra AB, Kabi Pharmacia AB and ACO AB. Lotta Blomgren holds a MSc in Chemical Engineering from Lund University, Sweden.